
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
Hippocrates

Researchers have recently uncovered significant insights into DEHP male reproductive toxicity, linking common plasticizers to severe hormonal imbalances. Di(2-ethylhexyl) phthalate (DEHP) is a ubiquitous environmental pollutant that frequently leaches from plastic products into our food, water, and medical devices. This exposure increasingly concerns medical professionals, particularly due to its established potential to disrupt the human endocrine system. Consequently, a comprehensive multi-omics study was conducted to evaluate how these pervasive chemicals impact testosterone levels in adult men.
The research utilized population data from the NHANES 2013-2016 surveys alongside experimental rat models to pinpoint specific biological disruptions. Consequently, the team found that oxidative DEHP metabolites, such as MEHHP and MEOHP, directly correlate with a monotonic increase in the risk of testosterone deficiency. In animal models, DEHP exposure caused visible damage to testicular structures and significantly reduced essential hormones like LH and FSH. Furthermore, multi-omics profiling identified hub genes, including NNT and ACSS1, which are primarily involved in mitochondrial energy metabolism and redox homeostasis.
Interestingly, the study employed computational screening and molecular docking to identify potential therapeutic compounds. As a result, ursolic acid emerged as a primary candidate to mitigate the toxic effects of DEHP on the male reproductive system. While the predicted stability of the ursolic acid-ACSS1 complex is promising, clinicians should note that further experimental validation remains necessary. Therefore, reducing environmental plastic exposure continues to be the primary recommendation for safeguarding male reproductive health and maintaining hormonal balance.
Research indicates that metabolites of DEHP interfere with the endocrine system, leading to a dose-response increase in the odds of testosterone deficiency in adult men by disrupting steroidogenesis and pituitary hormone signaling.
Computational profiling suggests that ursolic acid may stabilize key metabolic and redox networks affected by DEHP. However, clinical trials are still required to confirm its protective efficacy in human populations.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Gong Z et al. DEHP-induced male reproductive toxicity: Evidence from population studies, animal experiments, and multi-omics profiling. Ecotoxicol Environ Saf. 2026 Jun 04. doi: undefined. PMID: 42241798.
Dhar S et al. Phthalates as the silent saboteurs of male fertility via changes in semen quality: a systematic review. Reprod Biol Endocrinol. 2026 Mar 9. doi: 10.1186/s12958-026-01541-0.
Gouri K, Sinha P. Impact of DEHP Toxicity on Testis of Rat Leading to Disruption of Testis Histology. Toxicology International. 2023 Feb 7;29(4):507–514. doi: 10.18311/ti/2022/v29i4/30294.
"
A new study links DEHP plasticizer exposure to testosterone deficiency and explores molecular mechanisms and potential interventions like ursolic acid....
Last week

A meta-analysis in JAMA Oncology reveals a 3.5% pooled frequency of second primary malignant neoplasms (SPMs) following T-cell-engaging bispecific antibody therapy for NHL and MM. The findings emphasize the need for standardized long-term safety surveillance as these therapies move to earlier lines of treatment.
Today

India's free Swastha Nari HPV vaccination campaign is experiencing severe delays in Tamil Nadu. Digital consent mandates on the U-WIN platform and a ban on school-based vaccination are creating administrative bottlenecks, leaving thousands of crucial doses sitting unused in cold storage.
Today

A new study by Pacific OneHealth Hospitals reveals that over 50% of millennials in Delhi-NCR are overweight or obese. It highlights a critical metabolic health risk window between ages 30 and 44, during which visceral fat accumulation and hypertension rise sharply, driving future cardiovascular diseases.
Today

This study explores atomic-scale techniques like PEALD to engineer ZnO-Chitosan biointerfaces for medical implants. These interfaces exhibit superior immunomodulatory properties and antiseptic activity against pathogens, marking a significant advancement for next-generation medical devices.
Today

This case series details significant Lenacapavir drug-drug interactions in HIV patients. It highlights the risk of adrenal insufficiency with fluticasone and potential efficacy issues with clopidogrel, emphasizing the need for updated electronic medical record alerts to ensure patient safety.
Today